Medingenii

Medingenii Capital, based in Houston, Texas, is a venture capital firm specializing in early-stage investments in healthcare, medical devices, healthtech, and life sciences. With a clear focus on disruptive solutions addressing critical challenges in these fields, the firm leverages its deep connections within the Texas Medical Center ecosystem and a global network of co-investors and industry leaders to scale startups for growth and successful exits. Notable portfolio companies include Vitls, Ucardia, and Forest Devices, all of which innovate in life sciences and medical technology. Medingenii’s investment strategy targets healthtech startups, particularly those advancing genomic testing, patient engagement, and medical devices. The firm prefers to engage early, often leading or co-investing in rounds. Their average check size typically hovers around $1.5M. The leadership team, including key figures like Greg Campbell, Diane Yoo, and Eddie Patton, brings decades of entrepreneurial and investment expertise, with a strong emphasis on supporting underrepresented founders and female-led ventures. Medingenii’s unique blend of healthcare specialization and its commitment to diversity position it as a critical player for startups seeking to make a significant impact in the medical and health sectors.